MenQuadfi

Meningococcal quadrivalent conjugate vaccine · Sanofi Pasteur

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MenQuadfi, covering 2021-10-06 to 2026-08-18. Get the full timeline:

Most recent: EMA Authorised: MenQuadfi (Neisseria meningitidis group C polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group A polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group Y polysaccharide conjugated to tetanus toxoid;Neisseria meningitidis group W-135 polysaccharide conjugated to tetanus toxoid) — Sanofi Winthrop Industrie

See pricing